Why the study?
Does CRT-D provide benefit in patients in NYHA class III/IV, with LVEF of 35%, QRS width of 120 ms with a conventional indication for an ICD?
Does CRT-D provide benefit in patients in NYHA class III/IV, with LVEF of 35%, QRS width of 120 ms with a conventional indication for an ICD?
Answers are grounded in this paper and cite their sources.
The 2010 ESC Guidelines support the use of CRT-D in patients with NYHA class III/IV, LVEF of 35%, QRS width of 120 ms, and a conventional indication for an ICD.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Members et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: